BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Man F, Gawne PJ, T M de Rosales R. Nuclear imaging of liposomal drug delivery systems: A critical review of radiolabelling methods and applications in nanomedicine. Adv Drug Deliv Rev 2019;143:134-60. [PMID: 31170428 DOI: 10.1016/j.addr.2019.05.012] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 13.8] [Reference Citation Analysis]
Number Citing Articles
1 Gubert P, Gubert G, Oliveira RCD, Fernandes ICO, Bezerra IC, Ramos BD, Lima MFD, Rodrigues DT, Cruz AFND, Pereira EC, Ávila DS, Mosca DH. Caenorhabditis elegans as a Prediction Platform for Nanotechnology-Based Strategies: Insights on Analytical Challenges. Toxics 2023;11:239. [DOI: 10.3390/toxics11030239] [Reference Citation Analysis]
2 Ahmadi M, Emzhik M, Mosayebnia M. Nanoparticles labeled with gamma-emitting radioisotopes: an attractive approach for in vivo tracking using SPECT imaging. Drug Deliv Transl Res 2023. [PMID: 36811810 DOI: 10.1007/s13346-023-01291-1] [Reference Citation Analysis]
3 Ahmadi M, Khoramjouy M, Dadashzadeh S, Asadian E, Mosayebnia M, Geramifar P, Shahhosseini S, Ghorbani-bidkorpeh F. Pharmacokinetics and biodistribution studies of [99mTc]-Labeled ZIF-8 nanoparticles to pave the way for image-guided drug delivery and theranostics. Journal of Drug Delivery Science and Technology 2023. [DOI: 10.1016/j.jddst.2023.104249] [Reference Citation Analysis]
4 Li H, Luo Q, Zhang H, Ma X, Gu Z, Gong Q, Luo K. Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation. Chem Soc Rev 2023;52:47-96. [PMID: 36427082 DOI: 10.1039/d2cs00437b] [Reference Citation Analysis]
5 Priester MI, Ten Hagen TLM. Image-guided drug delivery in nanosystem-based cancer therapies. Adv Drug Deliv Rev 2023;192:114621. [PMID: 36402247 DOI: 10.1016/j.addr.2022.114621] [Reference Citation Analysis]
6 Behera A, Padhi S, Nayak AK. Engineered liposomes as drug delivery and imaging agents. Design and Applications of Theranostic Nanomedicines 2023. [DOI: 10.1016/b978-0-323-89953-6.00010-6] [Reference Citation Analysis]
7 Goel M, Mackeyev Y, Krishnan S. Radiolabeled nanomaterial for cancer diagnostics and therapeutics: principles and concepts. Cancer Nanotechnol 2023;14:15. [PMID: 36865684 DOI: 10.1186/s12645-023-00165-y] [Reference Citation Analysis]
8 Man F, Tang J, Swedrowska M, Forbes B, T M de Rosales R. Imaging drug delivery to the lungs: Methods and applications in oncology. Adv Drug Deliv Rev 2023;192:114641. [PMID: 36509173 DOI: 10.1016/j.addr.2022.114641] [Reference Citation Analysis]
9 Saxena T, Sie C, Lin K, Ye D, Saatchi K, Häfeli UO. Potential of Nuclear Imaging Techniques to Study the Oral Delivery of Peptides. Pharmaceutics 2022;14. [PMID: 36559303 DOI: 10.3390/pharmaceutics14122809] [Reference Citation Analysis]
10 Ahmed N, Sohail MF, Khurshid Z, Ammar A, Saeed AM, Shazia F, Gul S, Zia M. Synthesis, Characterization, and In Vivo Distribution of 99mTc Radiolabelled Docetaxel Loaded Folic Acid-Thiolated Chitosan Enveloped Liposomes. BioNanoSci 2022. [DOI: 10.1007/s12668-022-01053-2] [Reference Citation Analysis]
11 Cheng SH, Groseclose MR, Mininger C, Bergstrom M, Zhang L, Lenhard SC, Skedzielewski T, Kelley ZD, Comroe D, Hong H, Cui H, Hoover JL, Rittenhouse S, Castellino S, Jucker BM, Alsaid H. Multimodal imaging distribution assessment of a liposomal antibiotic in an infectious disease model. J Control Release 2022;352:199-210. [PMID: 36084816 DOI: 10.1016/j.jconrel.2022.08.061] [Reference Citation Analysis]
12 Korshunov DA, Buldakov MA, Sereda EE, Bukterov MV, Milto IV, Kondakova IV. Studies of the Antitumor Activity of Iodacetate in the Liposomal Form. Dokl Biochem Biophys 2022;507:278-82. [PMID: 36786986 DOI: 10.1134/S1607672922060059] [Reference Citation Analysis]
13 Jin R, Fu X, Pu Y, Fu S, Liang H, Yang L, Nie Y, Ai H. Clinical translational barriers against nanoparticle-based imaging agents. Adv Drug Deliv Rev 2022;191:114587. [PMID: 36309148 DOI: 10.1016/j.addr.2022.114587] [Reference Citation Analysis]
14 Alkandari AM, Alsayed YM, El-Hanbaly AM. Enhanced Efficacy of Radiopharmaceuticals When Using Technetium-99m-Labeled Liposomal Agents: Synthesis and Pharmacokinetic Properties. Biomedicines 2022;10. [PMID: 36428563 DOI: 10.3390/biomedicines10112994] [Reference Citation Analysis]
15 Gawne PJ, Pinto SMA, Nielsen KM, Keeling GP, Pereira MM, T M de Rosales R. Microwave-assisted synthesis of [(52)Mn]Mn-porphyrins: Applications in cell and liposome radiolabelling. Nucl Med Biol 2022;114-115:6-17. [PMID: 36088876 DOI: 10.1016/j.nucmedbio.2022.08.006] [Reference Citation Analysis]
16 Li P, Wang D, Hu J, Yang X. The role of imaging in targeted delivery of nanomedicine for cancer therapy. Adv Drug Deliv Rev 2022;189:114447. [PMID: 35863515 DOI: 10.1016/j.addr.2022.114447] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
17 Wu W, Li T. Deepening the understanding of the in vivo and cellular fate of nanocarriers. Adv Drug Deliv Rev 2022;189:114529. [PMID: 36064031 DOI: 10.1016/j.addr.2022.114529] [Reference Citation Analysis]
18 Poletto G, Evangelista L, Venturini F, Gramegna F, Seno F, Moro S, Vettor R, Realdon N, Cecchin D. Nanoparticles and Radioisotopes: A Long Story in a Nutshell. Pharmaceutics 2022;14:2024. [DOI: 10.3390/pharmaceutics14102024] [Reference Citation Analysis]
19 Munekane M, Kosugi A, Yamasaki M, Watanabe Y, Kannaka K, Sano K, Yamasaki T, Ogawara K, Mukai T. Biodistribution study of indium-111-labeled PEGylated niosomes as novel drug carriers for tumor-targeting. Journal of Drug Delivery Science and Technology 2022. [DOI: 10.1016/j.jddst.2022.103648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Cai Y, Qi J, Lu Y, He H, Wu W. The in vivo fate of polymeric micelles. Adv Drug Deliv Rev 2022;:114463. [PMID: 35905947 DOI: 10.1016/j.addr.2022.114463] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
21 Wang Z, Li J, Lin G, He Z, Wang Y. Metal complex-based liposomes: Applications and prospects in cancer diagnostics and therapeutics. J Control Release 2022;348:1066-88. [PMID: 35718211 DOI: 10.1016/j.jconrel.2022.06.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Lee JY, Chae JH, Hur MG, Yang SD, Kong YB, Lee J, Ju JS, Choi PS, Park JH. Theragnostic 64Cu/67Cu Radioisotopes Production With RFT-30 Cyclotron. Front Med 2022;9:889640. [DOI: 10.3389/fmed.2022.889640] [Reference Citation Analysis]
23 Gawne PJ, Man F, Blower PJ, T M de Rosales R. Direct Cell Radiolabeling for in Vivo Cell Tracking with PET and SPECT Imaging. Chem Rev 2022. [PMID: 35549242 DOI: 10.1021/acs.chemrev.1c00767] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
24 Fan W, Peng H, Yu Z, Wang L, He H, Ma Y, Qi J, Lu Y, Wu W. The long-circulating effect of pegylated nanoparticles revisited via simultaneous monitoring of both the drug payloads and nanocarriers. Acta Pharm Sin B 2022;12:2479-93. [PMID: 35646531 DOI: 10.1016/j.apsb.2021.11.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Liu L, Rambarran T, Muirhead B, Lasowski F, Sheardown H. A Radiolabeling Method for Precise Quantification of Polymers. Bioconjug Chem 2022. [PMID: 35353491 DOI: 10.1021/acs.bioconjchem.2c00047] [Reference Citation Analysis]
26 Roy I, Krishnan S, Kabashin AV, Zavestovskaya IN, Prasad PN. Transforming Nuclear Medicine with Nanoradiopharmaceuticals. ACS Nano 2022. [PMID: 35294165 DOI: 10.1021/acsnano.1c10550] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
27 Yilmaz D, Sharp PS, Main MJ, Simpson PB. Advanced molecular imaging for the characterisation of complex medicines. Drug Discovery Today 2022. [DOI: 10.1016/j.drudis.2022.03.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules 2022;27:1372. [PMID: 35209162 DOI: 10.3390/molecules27041372] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 18.0] [Reference Citation Analysis]
29 Phua VJX, Yang C, Xia B, Yan SX, Liu J, Aw SE, He T, Ng DCE. Nanomaterial Probes for Nuclear Imaging. Nanomaterials 2022;12:582. [DOI: 10.3390/nano12040582] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
30 Wilson CG, Aarons L, Augustijns P, Brouwers J, Darwich AS, De Waal T, Garbacz G, Hansmann S, Hoc D, Ivanova A, Koziolek M, Reppas C, Schick P, Vertzoni M, García-Horsman JA. Integration of advanced methods and models to study drug absorption and related processes: An UNGAP perspective. Eur J Pharm Sci 2021;:106100. [PMID: 34936937 DOI: 10.1016/j.ejps.2021.106100] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
31 Santos-Coquillat A, González MI, Clemente-Moragón A, González-Arjona M, Albaladejo-García V, Peinado H, Muñoz J, Ximénez Embún P, Ibañez B, Oliver E, Desco M, Salinas B. Goat Milk Exosomes As Natural Nanoparticles for Detecting Inflammatory Processes By Optical Imaging. Small 2021;:e2105421. [PMID: 34854563 DOI: 10.1002/smll.202105421] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
32 Mast MP, Modh H, Champanhac C, Wang JW, Storm G, Krämer J, Mailänder V, Pastorin G, Wacker MG. Nanomedicine at the crossroads - A quick guide for IVIVC. Adv Drug Deliv Rev 2021;179:113829. [PMID: 34174332 DOI: 10.1016/j.addr.2021.113829] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
33 Bonnet S, Elfatairi R, Franconi F, Roger E, Legeay S. Organic nanoparticle tracking during pharmacokinetic studies. Nanomedicine (Lond) 2021;16:2539-6. [PMID: 34814704 DOI: 10.2217/nnm-2021-0155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
34 Southcott L, Orvig C. Inorganic radiopharmaceutical chemistry of oxine. Dalton Trans 2021;50:16451-8. [PMID: 34709268 DOI: 10.1039/d1dt02685b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Mena-Giraldo P, Orozco J. Polymeric Micro/Nanocarriers and Motors for Cargo Transport and Phototriggered Delivery. Polymers (Basel) 2021;13:3920. [PMID: 34833219 DOI: 10.3390/polym13223920] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
36 Razzaghi MR, Ghazimoradi MH, Afzali S, Kamani E, Mohajerani E, Shirkavand A, Farivar S. Effect of a Low-Level Laser on Liposomal Doxorubicin Efficacy in a Melanoma Cell Line. J Lasers Med Sci 2021;12:e28. [PMID: 34733751 DOI: 10.34172/jlms.2021.28] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Díez-Villares S, Pellico J, Gómez-Lado N, Grijalvo S, Alijas S, Eritja R, Herranz F, Aguiar P, de la Fuente M. Biodistribution of 68/67Ga-Radiolabeled Sphingolipid Nanoemulsions by PET and SPECT Imaging. Int J Nanomedicine 2021;16:5923-35. [PMID: 34475757 DOI: 10.2147/IJN.S316767] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 Lee W, Il An G, Park H, Sarkar S, Ha YS, Huynh PT, Bhise A, Bhatt N, Ahn H, Pandya DN, Kim JY, Kim S, Jun E, Kim SC, Lee KC, Yoo J. Imaging Strategy that Achieves Ultrahigh Contrast by Utilizing Differential Esterase Activity in Organs: Application in Early Detection of Pancreatic Cancer. ACS Nano 2021. [PMID: 34405675 DOI: 10.1021/acsnano.1c05165] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
39 Lizoňová D, Frei S, Balouch M, Zadražil A, Štěpánek F. Multilobed Magnetic Liposomes Enable Remotely Controlled Collection, Transport, and Delivery of Membrane-Soluble Cargos to Vesicles and Cells. ACS Appl Bio Mater 2021;4:4833-40. [PMID: 35007032 DOI: 10.1021/acsabm.1c00106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mkhatshwa M, Moremi JM, Makgopa K, Manicum AE. Nanoparticles Functionalised with Re(I) Tricarbonyl Complexes for Cancer Theranostics. Int J Mol Sci 2021;22:6546. [PMID: 34207182 DOI: 10.3390/ijms22126546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
41 Musielak M, Potoczny J, Boś-Liedke A, Kozak M. The Combination of Liposomes and Metallic Nanoparticles as Multifunctional Nanostructures in the Therapy and Medical Imaging-A Review. Int J Mol Sci 2021;22:6229. [PMID: 34207682 DOI: 10.3390/ijms22126229] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
42 Chang CH, Chang MC, Chang YJ, Chen LC, Lee TW, Ting G. Translating Research for the Radiotheranostics of Nanotargeted 188Re-Liposome. Int J Mol Sci 2021;22:3868. [PMID: 33918011 DOI: 10.3390/ijms22083868] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
43 Wu W, Li T, Zheng Y. Editorial of Special Issue "The Biological Fate of Drug Nanocarriers". Acta Pharm Sin B 2021;11:850-1. [PMID: 33996403 DOI: 10.1016/j.apsb.2021.04.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
44 Xiao Q, Li X, Li Y, Wu Z, Xu C, Chen Z, He W. Biological drug and drug delivery-mediated immunotherapy. Acta Pharm Sin B 2021;11:941-60. [PMID: 33996408 DOI: 10.1016/j.apsb.2020.12.018] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 19.0] [Reference Citation Analysis]
45 Paolino D, Mancuso A, Cristiano MC, Froiio F, Lammari N, Celia C, Fresta M. Nanonutraceuticals: The New Frontier of Supplementary Food. Nanomaterials (Basel) 2021;11:792. [PMID: 33808823 DOI: 10.3390/nano11030792] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
46 Cressey P, Amrahli M, So PW, Gedroyc W, Wright M, Thanou M. Image-guided thermosensitive liposomes for focused ultrasound enhanced co-delivery of carboplatin and SN-38 against triple negative breast cancer in mice. Biomaterials 2021;271:120758. [PMID: 33774525 DOI: 10.1016/j.biomaterials.2021.120758] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
47 Huang YS, Hsu WC, Lin CH, Lo SN, Cheng CN, Lin MS, Lee TW, Chang CH, Lan KL. Bi-Functional Radiotheranostics of 188Re-Liposome-Fcy-hEGF for Radio- and Chemo-Therapy of EGFR-Overexpressing Cancer Cells. Int J Mol Sci 2021;22:1902. [PMID: 33672989 DOI: 10.3390/ijms22041902] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
48 Khan AA, T M de Rosales R. Radiolabelling of Extracellular Vesicles for PET and SPECT imaging. Nanotheranostics 2021;5:256-74. [PMID: 33654653 DOI: 10.7150/ntno.51676] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
49 Pellico J, Gawne PJ, T M de Rosales R. Radiolabelling of nanomaterials for medical imaging and therapy. Chem Soc Rev 2021;50:3355-423. [PMID: 33491714 DOI: 10.1039/d0cs00384k] [Cited by in Crossref: 50] [Cited by in F6Publishing: 60] [Article Influence: 25.0] [Reference Citation Analysis]
50 Kim EM, Jeong HJ. Liposomes: Biomedical Applications. Chonnam Med J 2021;57:27-35. [PMID: 33537216 DOI: 10.4068/cmj.2021.57.1.27] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 12.5] [Reference Citation Analysis]
51 Liu SY, Lo SN, Lee WC, Hsu WC, Lee TW, Chang CH. Evaluation of Nanotargeted 111In-Cyclic RGDfK-Liposome in a Human Melanoma Xenotransplantation Model. Int J Mol Sci 2021;22:1099. [PMID: 33499267 DOI: 10.3390/ijms22031099] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
52 Lahkar S, Das MK. Blood–brain-barrier crossing nanotheranostics in brain cancer. Multifunctional Theranostic Nanomedicines in Cancer 2021. [DOI: 10.1016/b978-0-12-821712-2.00007-4] [Reference Citation Analysis]
53 Kozlovskaya V, Alford A, Dolmat M, Ducharme M, Caviedes R, Radford L, Lapi SE, Kharlampieva E. Multilayer Microcapsules with Shell-Chelated 89 Zr for PET Imaging and Controlled Delivery. ACS Appl Mater Interfaces 2020;12:56792-804. [DOI: 10.1021/acsami.0c17456] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
54 Teng C, Lin C, Huang F, Xing X, Chen S, Ye L, Azevedo HS, Xu C, Wu Z, Chen Z, He W. Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease. Acta Pharm Sin B 2020;10:1521-33. [PMID: 32963947 DOI: 10.1016/j.apsb.2020.06.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
55 Fan W, Yu Z, Peng H, He H, Lu Y, Qi J, Dong X, Zhao W, Wu W. Effect of particle size on the pharmacokinetics and biodistribution of parenteral nanoemulsions. International Journal of Pharmaceutics 2020;586:119551. [DOI: 10.1016/j.ijpharm.2020.119551] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
56 Petrik M, Umlaufova E, Raclavsky V, Palyzova A, Havlicek V, Pfister J, Mair C, Novy Z, Popper M, Hajduch M, Decristoforo C. 68Ga-labelled desferrioxamine-B for bacterial infection imaging. Eur J Nucl Med Mol Imaging 2021;48:372-82. [PMID: 32734456 DOI: 10.1007/s00259-020-04948-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
57 van Moolenbroek GT, Patiño T, Llop J, Sánchez S. Engineering Intelligent Nanosystems for Enhanced Medical Imaging. Advanced Intelligent Systems 2020;2:2000087. [DOI: 10.1002/aisy.202000087] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 7.3] [Reference Citation Analysis]
58 Modak M, Frey MA, Yi S, Liu Y, Scott EA. Employment of targeted nanoparticles for imaging of cellular processes in cardiovascular disease. Curr Opin Biotechnol 2020;66:59-68. [PMID: 32682272 DOI: 10.1016/j.copbio.2020.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
59 Aranda-Lara L, Morales-Avila E, Luna-Gutiérrez MA, Olivé-Alvarez E, Isaac-Olivé K. Radiolabeled liposomes and lipoproteins as lipidic nanoparticles for imaging and therapy. Chem Phys Lipids 2020;230:104934. [PMID: 32562666 DOI: 10.1016/j.chemphyslip.2020.104934] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 4.7] [Reference Citation Analysis]
60 González MI, Martín-Duque P, Desco M, Salinas B. Radioactive Labeling of Milk-Derived Exosomes with 99mTc and In Vivo Tracking by SPECT Imaging. Nanomaterials (Basel) 2020;10:E1062. [PMID: 32486215 DOI: 10.3390/nano10061062] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 9.3] [Reference Citation Analysis]
61 Gaál A, Garay TM, Horváth I, Máthé D, Szöllősi D, Veres DS, Mbuotidem J, Kovács T, Tóvári J, Bergmann R, Streli C, Szakács G, Mihály J, Varga Z, Szoboszlai N. Development and In Vivo Application of a Water-Soluble Anticancer Copper Ionophore System Using a Temperature-Sensitive Liposome Formulation. Pharmaceutics 2020;12:E466. [PMID: 32443790 DOI: 10.3390/pharmaceutics12050466] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
62 Siafaka PI, Okur NÜ, Karantas ID, Okur ME, Gündoğdu EA. Current update on nanoplatforms as therapeutic and diagnostic tools: A review for the materials used as nanotheranostics and imaging modalities. Asian J Pharm Sci 2021;16:24-46. [PMID: 33613728 DOI: 10.1016/j.ajps.2020.03.003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 14.7] [Reference Citation Analysis]
63 Datta P, Ray S. Nanoparticulate formulations of radiopharmaceuticals: Strategy to improve targeting and biodistribution properties. J Labelled Comp Radiopharm 2020. [PMID: 32220029 DOI: 10.1002/jlcr.3839] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
64 Gawne PJ, Clarke F, Turjeman K, Cope AP, Long NJ, Barenholz Y, Terry SYA, de Rosales RTM. PET Imaging of Liposomal Glucocorticoids using 89Zr-oxine: Theranostic Applications in Inflammatory Arthritis. Theranostics 2020;10:3867-79. [PMID: 32226525 DOI: 10.7150/thno.40403] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
65 Cheng Y, Ji Y. Mitochondria-targeting nanomedicine self-assembled from GSH-responsive paclitaxel-ss-berberine conjugate for synergetic cancer treatment with enhanced cytotoxicity. Journal of Controlled Release 2020;318:38-49. [DOI: 10.1016/j.jconrel.2019.12.011] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 14.3] [Reference Citation Analysis]
66 Gabizon AA, de Rosales RTM, La-Beck NM. Translational considerations in nanomedicine: The oncology perspective. Adv Drug Deliv Rev 2020;158:140-57. [PMID: 32526450 DOI: 10.1016/j.addr.2020.05.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 5.7] [Reference Citation Analysis]
67 Pérez-Medina C, Teunissen AJP, Kluza E, Mulder WJM, van der Meel R. Nuclear imaging approaches facilitating nanomedicine translation. Adv Drug Deliv Rev 2020;154-155:123-41. [PMID: 32721459 DOI: 10.1016/j.addr.2020.07.017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
68 Shah J, Bhagat S, Singh S. Standard biological assays to estimate nanoparticle toxicity and biodistribution. Nanotoxicity 2020. [DOI: 10.1016/b978-0-12-819943-5.00004-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Wang H, Zheng M, Gao J, Wang J, Zhang Q, Fawcett JP, He Y, Gu J. Uptake and release profiles of PEGylated liposomal doxorubicin nanoparticles: A comprehensive picture based on separate determination of encapsulated and total drug concentrations in tissues of tumor-bearing mice. Talanta 2020;208:120358. [PMID: 31816795 DOI: 10.1016/j.talanta.2019.120358] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
70 Wu W, Li T. Unraveling the in vivo fate and cellular pharmacokinetics of drug nanocarriers. Adv Drug Deliv Rev 2019;143:1-2. [PMID: 31519263 DOI: 10.1016/j.addr.2019.08.003] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]